Amemiya, Yu
Kuwabara, Ayuka
Hisamune, Ryo
Zushi, Ryosuke
Kobata, Hitoshi
Yamamoto, Ryo
Inoue, Akihiko
Hifumi, Toru
Sakamoto, Tetsuya
Kuroda, Yasuhiro
Takasu, Akira
Yamakawa, Kazuma
,
Sawano, Hirotaka
Egawa, Yuko
Kato, Shunichi
Bunya, Naofumi
Kasai, Takehiko
Ijuin, Shinichi
Nakayama, Shinichi
Kanda, Jun
Kanou, Seiya
Kanou, Seiya
Takiguchi, Toru
Yokobori, Shoji
Takada, Hiroaki
Inoue, Kazushige
Takeuchi, Ichiro
Honzawa, Hiroshi
Kobayashi, Makoto
Hamagami, Tomohiro
Takayama, Wataru
Otomo, Yasuhiro
Maekawa, Kunihiko
Shimizu, Takafumi
Nara, Satoshi
Nasu, Michitaka
Takahashi, Kuniko
Hagiwara, Yoshihiro
Kushimoto, Shigeki
Fukuda, Reo
Ogura, Takayuki
Shiraishi, Shin-ichiro
Otani, Norio
Okamoto, Hiroshi
Kikuchi, Migaku
Watanabe, Kazuhiro
Nakagami, Takuo
Shoko, Tomohisa
Kitamura, Nobuya
Otani, Takayuki
Matsuoka, Yoshinori
Aoki, Makoto
Sakuraya, Masaaki
Arimoto, Hideki
Homma, Koichiro
Naito, Hiromichi
Nakao, Shunichiro
Okazaki, Tomoya
Yokoi, Hideto
Kunikata, Jun
Tahara, Yoshio
Article History
Received: 17 March 2026
Accepted: 11 May 2026
First Online: 22 May 2026
Declarations
Ethics approval and consent to participate: The SAVE-J II study was approved by the Clinical Research Ethics Committee of Kagawa University (Approval Number: 2018–110) as well as by the ethics committees of all participating institutions. Owing to the retrospective nature of the study, the requirement of informed consent was waived at all participating facilities.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.